| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2165/00003495-200868030-00005 |
| P698 | PubMed publication ID | 18257609 |
| P2093 | author name string | Petros Efthimiou | |
| Apostolos Kontzias | |||
| P2860 | cites work | Still's disease in the adult | Q24514809 |
| Molecular action of methotrexate in inflammatory diseases | Q24534771 | ||
| Safety of extended treatment with anakinra in patients with rheumatoid arthritis | Q24675209 | ||
| Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia | Q24816817 | ||
| Low dose methotrexate treatment in adult Still's disease | Q28319741 | ||
| Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 | ||
| Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. | Q31000488 | ||
| Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis | Q33245010 | ||
| Adult Still's disease and respiratory failure in a 74 year old woman | Q33340729 | ||
| Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice | Q33369142 | ||
| Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature | Q33370577 | ||
| Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis | Q33449383 | ||
| Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection | Q33502277 | ||
| Adult onset Still's disease and viral infections | Q33561094 | ||
| Adult onset Still's disease and related renal amyloidosis | Q33563529 | ||
| Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. | Q33564082 | ||
| Adult onset Still's disease: clinical experience with 18 patients over 15 years in northern India | Q33564566 | ||
| Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France | Q33578168 | ||
| Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. | Q33908108 | ||
| Secondary renal amyloidosis in adult onset Still's disease: case report and review of the literature | Q34036420 | ||
| Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease | Q34106179 | ||
| Association between adult-onset Still's disease and interleukin-18 gene polymorphisms | Q34158398 | ||
| Adult-onset Still's disease. Clinical course and outcome | Q34191960 | ||
| Adult Still's disease--recognition of a clinical syndrome and recent experience | Q34192253 | ||
| Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist | Q34251859 | ||
| Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines | Q34317221 | ||
| Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin | Q34362734 | ||
| Preliminary criteria for classification of adult Still's disease | Q34405573 | ||
| Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept | Q34595156 | ||
| Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. | Q53904782 | ||
| [Treatment of Still disease in adults with intravenous immunoglobulins]. | Q54017721 | ||
| Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. | Q54105583 | ||
| Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. | Q54660855 | ||
| Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. | Q54695048 | ||
| Association between HLA-DR B1 and clinical features of adult onset Still's disease in Korea | Q57214750 | ||
| The effect of etanercept and infliximab on the production of tumour necrosis factor α, interferon-γ and GM-CSF in in vivo activated intestinal T lymphocyte cultures | Q63727340 | ||
| Prolonged efficacy of infliximab for refractory adult-onset Still's disease. | Q64910808 | ||
| Carpal arthritis with ankylosis in late onset still's disease | Q67442609 | ||
| Adult-onset Still's disease | Q67790685 | ||
| Meningoencephalitis and peripheral neuropathy complicating adult Still's disease | Q68465106 | ||
| Adult Still's disease and mesangial glomerulonephritis. Report of two cases | Q68774213 | ||
| Myocarditis in adult Still's disease | Q68810870 | ||
| Carpal alterations in adult-onset Still disease, juvenile chronic arthritis, and adult-onset rheumatoid arthritis: comparative study | Q69409363 | ||
| Adult Still's disease complicated with adult respiratory distress | Q69657080 | ||
| Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA | Q70006816 | ||
| HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis | Q70057003 | ||
| Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists | Q70466614 | ||
| Fulminant hepatic failure in adult onset Still's disease | Q71322293 | ||
| [Fatal infectious complications in 2 patients with adult onset Still disease] | Q71414704 | ||
| Adverse effects of intravenous immunoglobulin therapy | Q71577292 | ||
| Ferritin levels and response to treatment in patients with Adult Still's disease | Q71608995 | ||
| Cyclosporin A in the treatment of adult Still's disease | Q71750961 | ||
| Adult onset Still's disease. 16 cases | Q71763302 | ||
| The Antiinflammatory Effects of Methotrexate are Mediated by Adenosine | Q72025640 | ||
| Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease | Q72137820 | ||
| Adult Still's disease associated with acute human parvovirus B19 infection | Q72218653 | ||
| Refractory adult onset Still's disease successfully treated with anakinra | Q43048915 | ||
| Adult onset Still's disease: response to Enbrel | Q43050955 | ||
| Infliximab in the treatment of adult Still's disease refractory to conventional therapy | Q43640728 | ||
| Chronic arthritis and carpo:metacarpal ratio in Japanese patients with adult Still's disease. | Q44572060 | ||
| Adult-onset Still's disease. Disease course and HLA associations | Q44682977 | ||
| Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil | Q44811238 | ||
| Clarithromycin in adult-onset Still's disease. Case report with a 1-year follow-up. | Q44896521 | ||
| Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. | Q45242187 | ||
| Leflunomide and azathioprine combination in refractory adult-onset Still's disease | Q45291859 | ||
| Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis | Q45411736 | ||
| Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease. | Q45722615 | ||
| Prolonged remission in adult-onset Still's disease with etanercept | Q46459558 | ||
| Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. | Q47958008 | ||
| Epidemiology and outcome of adult-onset Still's disease in Northern Norway. | Q50776899 | ||
| Severe hepatitis and pure red cell aplasia in adult Still's disease: good response to immunosuppressive therapy | Q73006925 | ||
| Intravenous immunoglobulin in the treatment of refractory adult Still's disease | Q73010787 | ||
| Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy | Q73103743 | ||
| Adult-onset Still's disease | Q73253985 | ||
| Inhibition of IFN-gamma signaling by glucocorticoids | Q73299810 | ||
| Treatment of adult Still's disease with dexamethasone, an alternative to prednisolone | Q73332388 | ||
| Bone marrow findings in patients with adult Still's disease | Q73369652 | ||
| Very high serum ferritin levels in adult-onset Still's disease | Q73428713 | ||
| Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease | Q73608471 | ||
| Adult Still's disease associated with Mycoplasma pneumoniae infection | Q73613201 | ||
| Liver transplant in adult Still's disease | Q73789431 | ||
| Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease | Q74267226 | ||
| Ferritin levels in adult Still's disease: any sugar? | Q74622786 | ||
| A case of adult onset Still's disease treated with infliximab | Q77761549 | ||
| Proposal for a new set of classification criteria for adult-onset still disease | Q78069999 | ||
| Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease | Q78667433 | ||
| Infliximab in a case of early adult-onset Still’s disease | Q79209668 | ||
| Successful treatment of a patient with refractory adult-onset still disease with anakinra | Q79241739 | ||
| Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease | Q79252972 | ||
| Histoplasmosis in a child with JRA on low-dose methotrexate | Q79370397 | ||
| Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease | Q80094944 | ||
| EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment | Q80147806 | ||
| Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim | Q80186977 | ||
| Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept | Q80194557 | ||
| [Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease. Experience in 2 cases] | Q80196917 | ||
| Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate | Q80201780 | ||
| Adult-onset Still's disease | Q80799523 | ||
| Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report | Q81238130 | ||
| Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis | Q81484758 | ||
| Listeria monocytogenes meningitis in a patient receiving etanercept for Still's disease | Q81572994 | ||
| ??? | Q24812856 | ||
| Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities. | Q35082963 | ||
| Fever of unknown origin: a review of 20 patients with Adult-onset Still's disease | Q35124991 | ||
| Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases | Q35547100 | ||
| Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease | Q35553291 | ||
| Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases | Q35555229 | ||
| Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences | Q35579173 | ||
| Diagnosis and management of adult onset Still's disease | Q35637158 | ||
| Safety of tumour necrosis factor-alpha antagonists | Q35734045 | ||
| Inhibition of IL-6 for the treatment of inflammatory diseases | Q35834922 | ||
| Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis | Q36062038 | ||
| Role of biological agents in immune-mediated inflammatory diseases | Q36067282 | ||
| A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis | Q36347465 | ||
| Adverse events associated with intravenous immunoglobulin therapy | Q36408094 | ||
| Low-dose methotrexate-induced pancytopenia | Q36459197 | ||
| Pathogenesis and management of adult-onset Still's disease | Q36583909 | ||
| Safety of intravenous immunoglobulin (IVIG) therapy | Q36743385 | ||
| Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution | Q36778450 | ||
| Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. | Q36855193 | ||
| Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy | Q37388584 | ||
| Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells | Q37443977 | ||
| Adult Still's disease: manifestations, disease course, and outcome in 62 patients | Q37670649 | ||
| Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure | Q39667880 | ||
| Adult Still's disease: review of 228 cases from the literature | Q39694157 | ||
| Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases | Q39782978 | ||
| Toxicity of low dose methotrexate in rheumatoid arthritis. | Q39841838 | ||
| Adult onset Still's disease: a study of 14 cases | Q40441853 | ||
| Successful treatment of a patient with refractory adult Still's disease by tacrolimus. | Q40452510 | ||
| Treatment of resistant adult still disease with infliximab: a report of 2 cases. | Q40467284 | ||
| Kawasaki disease: a decade of experience from North India | Q40498892 | ||
| Rapid responses to anakinra in patients with refractory adult-onset Still's disease | Q40507008 | ||
| Clinical manifestations, disease course, and complications of adult-onset Still's disease in Taiwan | Q40520885 | ||
| Longterm outcome of TNF blockade in adult-onset Still's disease | Q40532653 | ||
| Collapsing glomerulopathy in adult still's disease | Q40535064 | ||
| Fever of unknown origin: a report from China of 208 cases. | Q40548833 | ||
| Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease | Q40559609 | ||
| Liver failure in adult Still's disease during corticosteroid treatment | Q40566937 | ||
| Adult onset Still's disease as a cause of ARDS and acute respiratory failure | Q40576162 | ||
| Etanercept in the treatment of adult patients with Still's disease | Q40578875 | ||
| Risk factors for adult Still's disease. | Q40660734 | ||
| Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. | Q40693776 | ||
| Adult Still's disease: a multicenter survey of Japanese patients. | Q40759885 | ||
| Inhibition of macrophage proinflammatory cytokine expression by steroids and recombinant IL-10. | Q40785427 | ||
| Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease | Q40844217 | ||
| Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France | Q41163072 | ||
| Adult Still's disease. Part II. Management, outcome, and prognostic factors | Q41163086 | ||
| Sensorineural hearing loss in adult onset Still's disease | Q41203003 | ||
| Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years | Q41221844 | ||
| Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. | Q42054007 | ||
| Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial | Q42410300 | ||
| Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis | Q42516760 | ||
| Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra | Q42845046 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| adult-onset Still's disease | Q1187697 | ||
| P304 | page(s) | 319-337 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances | |
| P478 | volume | 68 |
| Q33884190 | 52-year-old man with arthralgias, fever, and fatigue |
| Q40298524 | A case of adult-onset Still's disease (AOSD)-like manifestations abruptly developing during confirmation of a diagnosis of metastatic papillary thyroid carcinoma |
| Q33385417 | A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD. |
| Q37782033 | A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature |
| Q53665027 | A woman with night sweats, arthritis, and two distinct eruptions. Adult-onset Still’s disease (AOSD). |
| Q34089790 | Adult Onset Still's Disease and Rocky Mountain Spotted Fever |
| Q40263834 | Adult onset Still's disease: experience from a tertiary care rheumatology unit. |
| Q33947548 | Adult-Onset Still's Disease Associated with Thyroid Dysfunction: Case Report and Review of the Literature |
| Q40263935 | Adult-Onset Still's Disease Masquerading as Sepsis in an Asplenic Active Duty Soldier |
| Q39366004 | Adult-onset Still disease: a rare disorder with a potentially fatal outcome |
| Q36842315 | Adult-onset Still's disease as a mask of Hodgkin lymphoma |
| Q38329024 | Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options |
| Q36208563 | Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers |
| Q40313877 | Adult-onset Still's disease: how to make a diagnosis in an atypical case |
| Q27495968 | Anti-Interleukin-1 Agents in Adult Onset Still's Disease |
| Q89099286 | Application of Fluorine-18-Deoxyglucose Positron Emission Tomography and Gallium Scan for Assessment in a Patient With Adult-Onset Still's Disease |
| Q34117115 | Aseptic meningitis in adult onset Still's disease |
| Q40326095 | Autoinflammatory syndromes/fever syndromes |
| Q30275550 | Case report of atypical Still's disease: a diagnosis of exclusion |
| Q47114537 | Diagnostic Challenge: A Report of Two Adult-Onset Still's Disease Cases. |
| Q34610098 | Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety |
| Q35133812 | Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives |
| Q34027630 | Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis |
| Q37625876 | Interstitial inflammation in visceral organs is a pathologic feature of adult-onset Still's disease. |
| Q33412732 | Life-threatening complications of adult-onset Still's disease |
| Q40395893 | Periodic fever syndrome/autoinflammatory syndrome |
| Q38463009 | Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge. |
| Q39446359 | Pulmonary involvement in adult Still's disease: Case report and brief review of literature |
| Q40317849 | Retrospective study of 61 patients with adult-onset Still's disease admitted with fever of unknown origin in China |
| Q35759676 | Still disease and the liver-an underappreciated association |
| Q43648042 | Therapeutic responses and prognosis in adult-onset Still's disease |
| Q41666895 | sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia |
Search more.